PROKOP, ALES (46 Ergebnisse)

Zustand: Good. 415 pp., hardcover, library handstamp to title page, else fine. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.

xiii, 324 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Zustand: New. The US is well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan. Series: Springerbriefs in Pharmaceutical Science and Drug Development. Num Pages: 145 pages, 16 colour illustrations, biography. BIC Classification: MBGR; TCB; TDCW. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 8. Weight in Grams: 237. . 2011. Paperback. . . . . Books ship from the US and Ireland.

3 volumes. 23 cm. original paperback. ca 1300 pp. ills, diagrams. references. index. ISBN\'s 1573311952, 1573313432. "Annals of the New York Academy of Sciences". -(few signs of use, otherwise (very) good). 1975g.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher.

Zustand: New. pp. 340.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. pp. 479.

Taschenbuch. Zustand: Neu. Intracellular Delivery III | Market Entry Barriers of Nanomedicines | Volkmar Weissig (u. a.) | Taschenbuch | xiii | Englisch | 2018 | Springer International Publishing | EAN 9783319828466 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Algal Biorefineries | Volume 1: Cultivation of Cells and Products | Rakesh Bajpai (u. a.) | Taschenbuch | xiii | Englisch | 2016 | Springer | EAN 9789402402674 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Systems Biology | Integrative Biology and Simulation Tools | Ale¿ Prokop (u. a.) | Taschenbuch | xxxi | Englisch | 2015 | Springer | EAN 9789400794542 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Intracellular Delivery II | Fundamentals and Applications | Ale¿ Prokop (u. a.) | Taschenbuch | xix | Englisch | 2017 | Springer | EAN 9789402402834 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Algal Biorefineries | Volume 2: Products and Refinery Design | Ale¿ Prokop (u. a.) | Taschenbuch | viii | Englisch | 2016 | Springer International Publishing | EAN 9783319366678 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Neuware -Algae offer potential to produce renewable chemicals and fuels using solar energy and carbon dioxide from atmosphere or in flue gases while simultaneously reducing the generation of greenhouse gases. Since these can be grown on marginal lands with micronutrients and macronutrients often present in waste streams, algae-based chemicals and fuels do not compete with foods. Still large-scale production of algae-based fuels and chemicals faces considerable technological and economical challenges and it would by necessity require a biorefinery approach wherein all the possible algal components are converted into value-added compounds. The present series on algal biorefineries represents a forum for reporting the state of the art of different technologies as well as the latest advances in this field. The volume II of this series complements the volume I in terms of the current state of the art. Different chapters in this volume address diverse issues ranging from genetically modifies algaeto new products to life-cycle analysis of algal products.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 568 pp. Englisch.

Taschenbuch. Zustand: Neu. Neuware -Growth in the pharmaceutical market has slowed down ¿ almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies ¿ the pharmaceutical market model is no longer functioning effectively and most pharmaceutical companies are failing to produce the innovation needed for success. This multi-authored new book looks at a vital strategy which can bring innovation to a market in need of new ideas and new products: Systems Biology (SB). Modeling is a significant task of systems biology. SB aims to develop and use efficient algorithms, data structures, visualization and communication tools to orchestrate the integration of large quantities of biological data with the goal of computer modeling. It involves the use of computer simulations of biological systems, such as the networks of metabolites comprise signal transduction pathways and gene regulatory networks to both analyze and visualize the complex connections of these cellular processes. SB involves a series of operational protocols used for performing research, namely a cycle composed of theoretical, analytic or computational modeling to propose specific testable hypotheses about a biological system, experimental validation, and then using the newly acquired quantitative description of cells or cell processes to refine the computational model or theory.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 588 pp. Englisch.

Buch. Zustand: Neu. Neuware -Growth in the pharmaceutical market has slowed down ¿ almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies ¿ the pharmaceutical market model is no longer functioning effectively and most pharmaceutical companies are failing to produce the innovation needed for success. This multi-authored new book looks at a vital strategy which can bring innovation to a market in need of new ideas and new products: Systems Biology (SB). Modeling is a significant task of systems biology. SB aims to develop and use efficient algorithms, data structures, visualization and communication tools to orchestrate the integration of large quantities of biological data with the goal of computer modeling. It involves the use of computer simulations of biological systems, such as the networks of metabolites comprise signal transduction pathways and gene regulatory networks to both analyze and visualize the complex connections of these cellular processes. SB involves a series of operational protocols used for performing research, namely a cycle composed of theoretical, analytic or computational modeling to propose specific testable hypotheses about a biological system, experimental validation, and then using the newly acquired quantitative description of cells or cell processes to refine the computational model or theory.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 588 pp. Englisch.

Buch. Zustand: Neu. Neuware -This volume is a continuation of Volume 1 following the previously published Editorial. More emphasis is given to novel nanocarrier designs, their characterization and function, and applications for drug discovery and treatment. A number of chapters will deal with nanofibers as a new major application within the biomedical field with a very high success rate particularly in wound healing and diabetic foot and spine injuries. A major new subdivision will deal with mathematical methods for the assembly of nanocarriers both for simulation and function.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 500 pp. Englisch.

Buch. Zustand: Neu. Neuware -Algae offer potential to produce renewable chemicals and fuels using solar energy and carbon dioxide from atmosphere or in flue gases while simultaneously reducing the generation of greenhouse gases. Since these can be grown on marginal lands with micronutrients and macronutrients often present in waste streams, algae-based chemicals and fuels do not compete with foods. Still large-scale production of algae-based fuels and chemicals faces considerable technological and economical challenges and it would by necessity require a biorefinery approach wherein all the possible algal components are converted into value-added compounds. The present series on algal biorefineries represents a forum for reporting the state of the art of different technologies as well as the latest advances in this field. The volume II of this series complements the volume I in terms of the current state of the art. Different chapters in this volume address diverse issues ranging from genetically modifies algaeto new products to life-cycle analysis of algal products.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 568 pp. Englisch.

Taschenbuch. Zustand: Neu. Neuware -A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new ¿drugs¿ will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently ¿nanomaterials¿ have been said to ¿show promise¿ but none of these promises have so far been ¿reduced¿ to human clinical practice.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 468 pp. Englisch.

Buch. Zustand: Neu. Neuware -Over the past century, the majority of chemical and energy needs of our industrial society has originated from fossilized carbon sources (coal, crude oil, natural gas). Increasingly, there is a realization that utilization of the fossilized carbon sources has adverse environmental consequences in the form of increasing concentration of greenhouse gases. We are also becoming aware of the limited nature of these resources. As a result, considerable efforts are being made to produce chemicals and fuels from renewable resources such as forest products, agricultural residues and plant products. All of these systems capture solar energy and atmospheric carbon dioxide as a part of the natural carbon cycle. Serious research efforts are also underway, targeting cultivation of photosynthetic autotrophic microbes for the production of biomass and lipids. In this category, algae appears to offer the most potential for capturing solar energy and atmospheric carbon dioxide and delivering sufficient quantities of biomass/lipids that can offset the fossilized carbon utilization in a meaningful manner without impacting food output adversely. However, several advances, both technologically as well as politically, are needed before we can realize its full potential. It is also clear that a biorefinery approach must be undertaken in order to harvest renewable energy and chemicals from algae economically.This edited, multi-authored volume on Algal Biorefineries will document new advances involving algae-based technology.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 340 pp. Englisch.

Taschenbuch. Zustand: Neu. Neuware -This volume is a continuation of Volume 1 following the previously published Editorial. More emphasis is given to novel nanocarrier designs, their characterization and function, and applications for drug discovery and treatment. A number of chapters will deal with nanofibers as a new major application within the biomedical field with a very high success rate particularly in wound healing and diabetic foot and spine injuries. A major new subdivision will deal with mathematical methods for the assembly of nanocarriers both for simulation and function.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 500 pp. Englisch.

Taschenbuch. Zustand: Neu. Neuware -Over the past century, the majority of chemical and energy needs of our industrial society has originated from fossilized carbon sources (coal, crude oil, natural gas). Increasingly, there is a realization that utilization of the fossilized carbon sources has adverse environmental consequences in the form of increasing concentration of greenhouse gases. We are also becoming aware of the limited nature of these resources. As a result, considerable efforts are being made to produce chemicals and fuels from renewable resources such as forest products, agricultural residues and plant products. All of these systems capture solar energy and atmospheric carbon dioxide as a part of the natural carbon cycle. Serious research efforts are also underway, targeting cultivation of photosynthetic autotrophic microbes for the production of biomass and lipids. In this category, algae appears to offer the most potential for capturing solar energy and atmospheric carbon dioxide and delivering sufficient quantities of biomass/lipids that can offset the fossilized carbon utilization in a meaningful manner without impacting food output adversely. However, several advances, both technologically as well as politically, are needed before we can realize its full potential. It is also clear that a biorefinery approach must be undertaken in order to harvest renewable energy and chemicals from algae economically.This edited, multi-authored volume on Algal Biorefineries will document new advances involving algae-based technology.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 340 pp. Englisch.

Buch. Zustand: Neu. Neuware -A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new ¿drugs¿ will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently ¿nanomaterials¿ have been said to ¿show promise¿ but none of these promises have so far been ¿reduced¿ to human clinical practice.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 468 pp. Englisch.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new 'drugs' will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently 'nanomaterials' have been said to 'show promise' but none of these promises have so far been 'reduced' to human clinical practice.The focus of this volume is on cancer indication since the majority of published research relates to this application; within that, we focus on solid tumors (solid malignancies). Our aim is critically to evaluate whether nanomaterials, both non-targeted and targeted to specific cells, could be of therapeutic benefit in clinical practice. The emphasis of this volume will be on pharmacokinetics (PK) and pharmacodynamics (PD) in animal and human studies.Apart from the case of exquisitely specific antibody-based drugs, the development of target-specific drug-carrier delivery systems has not yet been broadly successful at the clinical level. It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available. Therefore, successful development of site-selective drug delivery systems will need to include not only the development of suitable carriers, but also the development of drug entities that meet the required PK/PD profile.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Algae offer potential to produce renewable chemicals and fuels using solar energy and carbon dioxide from atmosphere or in flue gases while simultaneously reducing the generation of greenhouse gases. Since these can be grown on marginal lands with micronutrients and macronutrients often present in waste streams, algae-based chemicals and fuels do not compete with foods. Still large-scale production of algae-based fuels and chemicals faces considerable technological and economical challenges and it would by necessity require a biorefinery approach wherein all the possible algal components are converted into value-added compounds. The present series on algal biorefineries represents a forum for reporting the state of the art of different technologies as well as the latest advances in this field. The volume II of this series complements the volume I in terms of the current state of the art. Different chapters in this volume address diverse issues ranging from genetically modifies algaeto new products to life-cycle analysis of algal products.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new 'drugs' will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently 'nanomaterials' have been said to 'show promise' but none of these promises have so far been 'reduced' to human clinical practice.The focus of this volume is on cancer indication since the majority of published research relates to this application; within that, we focus on solid tumors (solid malignancies). Our aim is critically to evaluate whether nanomaterials, both non-targeted and targeted to specific cells, could be of therapeutic benefit in clinical practice. The emphasis of this volume will be on pharmacokinetics (PK) and pharmacodynamics (PD) in animal and human studies.Apart from the case of exquisitely specific antibody-based drugs, the development of target-specific drug-carrier delivery systems has not yet been broadly successful at the clinical level. It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available. Therefore, successful development of site-selective drug delivery systems will need to include not only the development of suitable carriers, but also the development of drug entities that meet the required PK/PD profile.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Algae offer potential to produce renewable chemicals and fuels using solar energy and carbon dioxide from atmosphere or in flue gases while simultaneously reducing the generation of greenhouse gases. Since these can be grown on marginal lands with micronutrients and macronutrients often present in waste streams, algae-based chemicals and fuels do not compete with foods. Still large-scale production of algae-based fuels and chemicals faces considerable technological and economical challenges and it would by necessity require a biorefinery approach wherein all the possible algal components are converted into value-added compounds. The present series on algal biorefineries represents a forum for reporting the state of the art of different technologies as well as the latest advances in this field. The volume II of this series complements the volume I in terms of the current state of the art. Different chapters in this volume address diverse issues ranging from genetically modifies algaeto new products to life-cycle analysis of algal products.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past century, the majority of chemical and energy needs of our industrial society has originated from fossilized carbon sources (coal, crude oil, natural gas). Increasingly, there is a realization that utilization of the fossilized carbon sources has adverse environmental consequences in the form of increasing concentration of greenhouse gases. We are also becoming aware of the limited nature of these resources. As a result, considerable efforts are being made to produce chemicals and fuels from renewable resources such as forest products, agricultural residues and plant products. All of these systems capture solar energy and atmospheric carbon dioxide as a part of the natural carbon cycle. Serious research efforts are also underway, targeting cultivation of photosynthetic autotrophic microbes for the production of biomass and lipids. In this category, algae appears to offer the most potential for capturing solar energy and atmospheric carbon dioxide and delivering sufficient quantities of biomass/lipids that can offset the fossilized carbon utilization in a meaningful manner without impacting food output adversely. However, several advances, both technologically as well as politically, are needed before we can realize its full potential. It is also clear that a biorefinery approach must be undertaken in order to harvest renewable energy and chemicals from algae economically.This edited, multi-authored volume on Algal Biorefineries will document new advances involving algae-based technology.